Search

everythinglearnresearchcommunity

for

Search:↓

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

New genes and pathways are important for testosterone production and male sexual development.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.